Araceli Biosciences Launches Endeavor Live Cell for Kinetic Imaging in Drug Discovery

May 20, 2026
Araceli Biosciences has introduced Endeavor Live Cell, an imaging system designed to enable rapid kinetic imaging for large-scale screening in AI-driven drug discovery workflows.

Araceli Biosciences announced in a press release the launch of Endeavor Live Cell, an imaging system designed for rapid kinetic imaging in large-scale screening campaigns. The system extends Araceli’s imaging platform into dynamic biology, supporting Lab-in-the-Loop workflows used in AI-driven drug discovery.

Endeavor Live Cell enables approximately four-minute imaging intervals across entire 1536-well plates, allowing researchers to monitor cellular processes as they occur. The system supports studies involving compound response, cell health monitoring, phenotypic screening, organoid growth, and other kinetic assays requiring frequent timepoints.

Developed in partnership with Okolab, the system combines Okolab’s live cell incubation and environmental control technology with Araceli’s imaging platform. This integration provides stable environmental conditions along with high-speed imaging and automation compatibility, enabling consistent data collection at scale.

Araceli positions Endeavor Live Cell as part of its imaging infrastructure for AI-enabled drug discovery, aiming to help scientists generate high-quality cellular data for automated experimental workflows.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more